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Objectives: Determine the clinical impact and predic-
tors of in-graft thrombus formation after EVAR.
Methods: A prospective endovascular aneurysm repair
(EVAR) database with 473 patients treated from 2000 to
2012 was searched. All postoperative computed tomogra-
phy angiographies (CTAs) were scrutinized for in-graft
thrombus using three-dimensional dedicated software. Pa-
tients with main body thrombus thickness >2 mm in >25%
of the graft circumference were selected for the study
group and compared with controls. Primary end point
was freedom from thromboembolic events. Estimates
were obtained using Kaplan-Meier plots. Secondary end
points included clinical, morphologic, and device-related
characteristics and were tested using a multivariable model.
Results: The study group included 68 patients
(16.4%). Median follow-up was 3.5 years (interquartile
range, 2.0-5.5 years). Mural thrombus was identiﬁed on
the 30-day CTA in 22 patients (32.4%) and up to 1 year
in 25 (36.7%). Endograft or limb occlusions occurred in
17 patients (4.1%), three in the thrombus group (4.4%; P
¼ .89). Freedom from thromboembolic events at 5 years
was 95% for the study group and 94% for controls (P ¼
.97; Fig). Smoking (hazard ratio [HR], 2.9; 95% conﬁ-
dence interval [CI], 1.6-5.2), polyester-based endografts
(HR, 3.8; 95% CI, 1.8-8.0), aortouniiliac (HR, 5.1; 95%Fig. Kaplan-Meier estimates for freedom from thromboembolic
events.CI, 2.0-13.1), and barrel conﬁguration (HR, 3.3; 95%
CI, 1.7-6.4) were associated with thrombus accumulation.
Conclusions: Mural thrombus formation within the
main-body of the endograft is related to smoking, aortouniiliac
design, main-body barrel conﬁguration, and polyester graft
fabric but has no effect on thromboembolic events over time.
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Objectives: To analyze total aortic arch reconstruction
in a contemporary comparison of current open and endo-
vascular repair.
Methods: Open (group 1) and endovascular proce-
dures (group 2) during 2007-2013 were reviewed. Endo-
vascular repair (only landing zone 0-1), with or without
hybrid adjunct, was selected for patients at high comorbid-
ity and ﬁt anatomy. Early and midterm mortality and major
complications were assessed.
Results: Overall, 100 (78 males; mean age, 68 years)
consecutive procedures performed; 29 were in group 1.
Seven among the 71 in group 2 were treated with branched
or chimney endograft, and 64 with partial or total
debranching and straight endograft. Patients in group 1
were younger (mean age, 61.9 vs 70.8 years; P ¼ .03),
more frequently females (48.2% vs 11.3%; P < .001) with
less cardiac (6.9% vs 38.2%; P ¼ .001), hypertensive
(58.5% vs 88.4%; P ¼ .002) and peripheral arterial (0% vs
16%; P ¼ .031) disease. At 30 days there were four deaths
in group 1 and six in group 2 (13.8% vs 8.5%; odds ratio,
1.7; 95% conﬁdence interval, 0.45-6.66; P ¼ .47), and
one stroke in group 1 and four in group 2 (odds ratio,
0.59; 95% conﬁdence interval, 0.06-5.59; P ¼ 1). No spi-
nal cord ischemia occurred in group 1 and two in group 2.
Two perioperative bleedings (one fatal) and one renal fail-
ure leading to death after 2 months occurred in group 1.
Three retrograde dissections (one fatal) were detected in
group 2. According to Kaplan-Meier estimates, survival at
48 months was 69.8% in group 1 and 78.7% in group 2
(P ¼ .60). Four reinterventions and four endoleaks were
recorded in group 2 at mean follow-up of 26.2 months.
Conclusions: Despite the higher comorbidity in pa-
tients undergoing endovascular aortic arch repair, no differ-
ence were detected in perioperative mortality, neurologic
complications, and 48-month survival in the two groups. An
endovascular approachmay be a valid alternative to open sur-
gery when morphologically feasible also in average-risk pa-
tients. However, a larger concurrent comparison and longer
follow-up is needed to conﬁrm this information.
